Paxil and pregnancy

Study links Paxil use in first trimester of to serious birth defects

Results of a scientific study indicate birth defects in infants born to women taking , including Paxil, during the first trimester of . In fact the study revealed a greater risk for women who took Paxil (paroxetine) in the first trimester, as opposed to other antidepressents.

As a result of the study, in September 2005 drug manufacturer GlaxoSmithKline informed health care professionals that it was updating the subsection of the PRECAUTIONS section of the labels for the drug Paxil (paroxetine HCI) and Paxil CR controlled-release tablets to indicate the Paxil side effects.

The study revealed a greater risk for overall birth defects for women using proxetine, and an increased risk for heart defects specifically. Read more about Paxil and birth defects.

Do you have a Paxil claim?

If you or a loved one has a child born with paxil birth defects, you may have a claim against the drug manufacturer.

Please contact our Paxil attorneys today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.


Latest News

Parents file birth defect lawsuit against Zoloft

Zoloft 150x150 Parents file birth defect lawsuit against ZoloftA group of parents have filed a lawsuit against the makers of Zoloft alleging the antidepressant caused their children severe birth defects. The lawsuit was filed in St. Clair County Circuit Court against Pfizer Inc.

Read the rest of this entry »

Two studies show dangers of SSRI use during pregnancy

sleeping baby 150x150 Two studies show dangers of SSRI use during pregnancyUsing antidepressant known as selective serotonin reuptake inhibitors, or SSRIs, during can increase the risk of various birth defects, whether the drugs are used early or late in , according to two studies published in the past six months.

Read the rest of this entry »

Another study shows PPHN risk with SSRI exposure

BritishMedicalJournal Logo Another study shows PPHN risk with SSRI exposureA new study, published in the January 12 issue of the British Medical Journal, adds more evidence that known as selective serotonin reuptake inhibitors, or SSRIs, when used during , can increase the chances that the newborn will have a life-threatening lung defect known as persistent pulmonary hypertension (PPHN).

Read the rest of this entry »